Published in Rev Esp Cardiol on May 01, 2002
Prognostic value of increased carbohydrate antigen in patients with heart failure. World J Cardiol (2014) 0.75
Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop (2009) 2.13
Survival in New York Heart Association class IV heart failure patients treated with cardiac resynchronization therapy compared with patients on optimal pharmacological treatment. Europace (2010) 1.55
Donor/recipient sex mismatch and survival after heart transplantation: only an issue in male recipients? An analysis of the Spanish Heart Transplantation Registry. Transpl Int (2014) 1.44
Benefit of Neoral C2 monitoring in de novo cardiac transplant recipients receiving basiliximab induction. Transplantation (2008) 1.44
Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy. Europace (2009) 1.44
[Neurohormonal activation in congestive heart failure: does it normalize after heart transplantation?]. Rev Esp Cardiol (2004) 1.41
[Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic]. Rev Esp Cardiol (2007) 1.08
Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Am Heart J (2002) 1.04
Multidimensional analysis of treatment adherence in patients with multiple chronic conditions. A cross-sectional study in a tertiary hospital. Patient Educ Couns (2010) 0.98
Optimizing the programation of cardiac resynchronization therapy devices in patients with heart failure and left bundle branch block. Am J Cardiol (2007) 0.97
Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration. J Card Fail (2010) 0.93
Assessment of peripheral endothelial-dependent vasodilatation within the first year after heart transplantation. J Heart Lung Transplant (2009) 0.91
Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage. PLoS Negl Trop Dis (2010) 0.91
The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: rationale and design. Am Heart J (2013) 0.90
Regulator of calcineurin 1 mediates pathological vascular wall remodeling. J Exp Med (2011) 0.90
Allogeneic adipose stem cell therapy in acute myocardial infarction. Eur J Clin Invest (2014) 0.90
Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure. J Heart Lung Transplant (2006) 0.90
Randomized clinical trial of the effectiveness of a home-based intervention in patients with heart failure: the IC-DOM study. Rev Esp Cardiol (2009) 0.87
Usefulness of ventricular dyssynchrony measured using M-mode echocardiography to predict response to resynchronization therapy. Am J Cardiol (2007) 0.86
Kv1.3 channels modulate human vascular smooth muscle cells proliferation independently of mTOR signaling pathway. Pflugers Arch (2014) 0.85
Initial experience with bosentan therapy in patients considered ineligible for heart transplantation because of severe pulmonary hypertension. Clin Transplant (2006) 0.85
Relation of response to cardiac resynchronization therapy to left ventricular reverse remodeling. Am J Cardiol (2006) 0.84
Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance. Int J Cardiol (2011) 0.83
Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune response. J Heart Lung Transplant (2008) 0.83
In vitro characterization of aldosterone and cAMP effects in mouse distal convoluted tubule cells. Am J Physiol Renal Physiol (2004) 0.83
Protein arginine methyl transferases-3 and -5 increase cell surface expression of cardiac sodium channel. FEBS Lett (2013) 0.83
The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation. Transplant Rev (Orlando) (2009) 0.83
Aragon workers' health study--design and cohort description. BMC Cardiovasc Disord (2012) 0.82
Myocardial deformation analysis in Chagas heart disease with the use of speckle tracking echocardiography. J Card Fail (2011) 0.80
Long-term prognostic value of elevated heart rate one year after heart transplantation. Int J Cardiol (2013) 0.79
Effects of cryopreservation on the immunogenicity of porcine arterial allografts in early stages of transplant vasculopathy. Cryobiology (2005) 0.78
[Heart transplantation in an HIV-1-infected patient with ischemic cardiomyopathy and severe pulmonary hypertension]. Rev Esp Cardiol (2011) 0.78
[Influence of cardiopathy etiology on responses to cardiac resynchronization therapy]. Rev Esp Cardiol (2007) 0.78
Clinical recommendations for the use of everolimus in heart transplantation. Transplant Rev (Orlando) (2010) 0.78
[Modulation of the beta-adrenergic system during acute myocardial infarction: rationale for a new clinical trial]. Rev Esp Cardiol (2011) 0.78
Oxidized LDL, lipoprotein (a) and other emergent risk factors in acute myocardial infarction (FORTIAM study). Rev Esp Cardiol (2009) 0.78
Microbiologic features and outcome of pneumonia in transplanted patients. Diagn Microbiol Infect Dis (2006) 0.78
[Specialized care program for end-stage heart failure patients. Initial experience in a heart failure unit]. Rev Esp Cardiol (2006) 0.78
Short-term (28 days) prognosis between genders according to the type of coronary event (Q-wave versus non-Q-wave acute myocardial infarction versus unstable angina pectoris). Am J Cardiol (2004) 0.78
Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation. Clin Transplant (2013) 0.77
Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes. Helicobacter (2004) 0.77
Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy. Eur J Heart Fail (2010) 0.77
Effect of a training program for primary care physicians on the optimization of beta-blocker treatment in elderly patients with heart failure. Rev Esp Cardiol (2010) 0.76
Epitope mapping of mitochondrial adenine nucleotide translocase-1 in idiopathic dilated cardiomyopathy. J Mol Cell Cardiol (2002) 0.76
Short-term transdermal estradiol enhances nitric oxide synthase III and estrogen receptor mRNA expression in arteries of women with coronary artery disease. Int J Cardiol (2005) 0.76
[Endothelial function and high-sensitivity C-reactive protein levels in patients with Chagas disease living in a nonendemic area]. Rev Esp Cardiol (2011) 0.76
Heart transplantation in HIV-infected patients: more cases in Europe. J Heart Lung Transplant (2011) 0.76
[Risk stratification in the chest pain unit: an unresolved problem]. Rev Esp Cardiol (2005) 0.75
[Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic]. Enferm Infecc Microbiol Clin (2008) 0.75
Adrenomedullin messenger RNA expression is increased in myocardial tissue of patients with idiopathic dilated cardiomyopathy. J Heart Lung Transplant (2004) 0.75
Severe aortic regurgitation and reduced left ventricular ejection fraction: outcomes after isolated aortic valve replacement and combined surgery. J Heart Lung Transplant (2009) 0.75
[Association of everolimus with tacrolimus during the first year after heart transplantation: initial experience]. Med Clin (Barc) (2013) 0.75
[Fixed-dose compounds and the secondary prevention of ischemic heart disease]. Rev Esp Cardiol (2011) 0.75
[Treatment of atrial fibrillation at different levels of health care]. Med Clin (Barc) (2007) 0.75
CD4+CD45RO+CD25-/lowCD127+: CD4+CD45RO+CD25hiCD127-/low Ratio in Peripheral Blood: A Useful Biomarker to Detect Cardiac Allograft Vasculopathy in Heart Transplanted Patients. Transplantation (2015) 0.75
[Intermediate coronary care units: rationale, infrastructure, equipment, and referral criteria]. Rev Esp Cardiol (2007) 0.75
[Clinical characteristics, management, and prognosis of patients with acute myocardial infarction not admitted to the coronary care unit. Usefulness of an intermediate care unit as the initial admission site]. Rev Esp Cardiol (2003) 0.75
Systematic review of three decades of Spanish cardiovascular epidemiology: improving translation for a future of prevention. Eur J Prev Cardiol (2012) 0.75
Technetium 99m-labeled tetrofosmin and iodine 123-labeled metaiodobenzylguanidine scintigraphy in the assessment of transmyocardial laser revascularization. J Thorac Cardiovasc Surg (2003) 0.75
[The Spanish National Cardiovascular Research Center: a new phase]. Rev Esp Cardiol (2008) 0.75
MWP phase shifters integrated in PbS-SU8 waveguides. Opt Express (2015) 0.75
In memory of an exceptional cardiologist and collegague: Magda Heras i Fortuny (1953-2014). Rev Esp Cardiol (Engl Ed) (2014) 0.75
[Impaired endothelium-dependent forearm vasodilation in idiopathic dilated cardiomyopathy is related to severe left ventricular dysfunction and elevated serum tumor necrosis factor levels]. Rev Esp Cardiol (2005) 0.75
[Long-term prognosis of women with non-ST-segment elevation acute coronary syndromes. a case-control study]. Rev Esp Cardiol (2002) 0.75